MEI Pharma, Inc. Changes Name to Lite Strategy, Inc. and Introduces New NASDAQ Ticker 'LITS'
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Sep 10 2025
0mins
Should l Buy ?
Source: Newsfilter
Corporate Rebranding: MEI Pharma, Inc. will rebrand as Lite Strategy, Inc. and change its NASDAQ ticker from MEIP to LITS, reflecting its focus on digital asset treasury management, particularly with Litecoin (LTC) as a primary reserve asset.
Strategic Partnerships: The company is collaborating with GSR Ventures for liquidity and risk management in its LTC treasury strategy, while also continuing to explore new drug development opportunities.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
